Cohort of Cord Blood Bank
1 other identifier
observational
2,000
1 country
1
Brief Summary
The objective of this observational study was to establish a cohort of umbilical cord blood stored in Tianjin Cord Blood Bank.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2025
CompletedFirst Submitted
Initial submission to the registry
August 1, 2025
CompletedFirst Posted
Study publicly available on registry
November 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
November 25, 2025
March 1, 2025
1.8 years
August 1, 2025
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health status
The health status of people stored umbilical cord blood
The diseases status of participants will be assessed at baseline and at follow-up visits every 3 to 5 years, up to 10 years. The events include the occurrence of childhood diseases at baseline, as well as disease progression or death during follow-up.
Eligibility Criteria
People stored umbilical cord blood in Tianjin Cord Blood Bank
You may qualify if:
- Voluntarily participated in this study and provided signed informed consent forms.
- People stored umbilical cord blood in Tianjin Cord Blood Bank.
- The information registered at the time of storage is complete and the contact details are genuine and available.
You may not qualify if:
- Refusing to answer the researcher's phone or refusing to accept the investigation.
- People who are unable or unsuitable to participate in the study for various other reasons .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, 300000, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2025
First Posted
November 25, 2025
Study Start
March 25, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2030
Last Updated
November 25, 2025
Record last verified: 2025-03